Pancreas · 2019 · 385 citations · 250 references
MedicineOncologySurgeryEndocrine OncologyEndocrine SurgerySurgical OncologyEndocrine Tumor SurgeryEndocrine TumorsNeuroendocrine Tumor SurgeryNeuroendocrine TumorsPancreatic CancerPancreatic SurgeryPancreatic Endocrine SurgeryPancreatic Neuroendocrine NeoplasmsPancreatic Neuroendocrine Tumor ResectionPancreatic Neuroendocrine Tumor Surgery
This manuscript is the result of the North American Neuroendocrine Tumor Society consensus conference on the surgical management of pancreatic neuroendocrine tumors from July 19 to 20, 2018. The group reviewed a series of questions of specific interest to surgeons taking care of patients with pancreatic neuroendocrine tumors, and for each, the available literature was reviewed. What follows are these reviews for each question followed by recommendations of the panel.
250
Phase 3 Trial of <sup>177</sup> Lu-Dotatate for Midgut Neuroendocrine Tumors
Jonathan Strosberg, Ghassan El‐Haddad, Edward M. Wolin et al. · New England Journal of Medicine · 2017 · 3.2K citations · Full text
Medicine, Oncology, Pharmacology +17
Everolimus for Advanced Pancreatic Neuroendocrine Tumors
James C. Yao, Manisha H. Shah, Tetsuhide Ito et al. · New England Journal of Medicine · 2011 · 2.8K citations · Full text
Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
Éric Raymond, Laëtitia Dahan, Jean‐Luc Raoul et al. · New England Journal of Medicine · 2011 · 2.5K citations
Medicine, Oncology, Pharmacology +11
Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors
Martyn Caplin, Marianne Pavel, Jarosław B. Ćwikła et al. · New England Journal of Medicine · 2014 · 1.9K citations · Full text
Medicine, Endocrinology, Oncology +17